First NIH-funded clinical trial in the US using umbilical cord derived mesenchymal stem cells for the treatment of patients with new onset type 1 diabetes Type 1 diabetes (T1D) is a chronic condition in which the body’s own immune system attacks and destroys...
SYDNEY–(BUSINESS WIRE)–NeuClone Pharmaceuticals Ltd (NeuClone), a clinical-stage biopharmaceutical company exclusively focused on developing high-quality biosimilar products, today announced that NeuCeptin, a biosimilar candidate of...
BOSTON–(BUSINESS WIRE)– Cerevance a clinical stage biopharmaceutical company advancing new medicines for brain diseases, announced today the initiation of a Phase 2 clinical trial of CVN424, an oral, first-in-class compound that selectively modulates a...
NEW YORK, Dec. 04, 2019 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental...
SPRING HOUSE, Pa., Dec. 4, 2019 /PRNewswire/ — Cognizance Biomarkers, LLC, a wholly-owned subsidiary of Evogen Inc., a leader in proteomic and genomic-based testing for improved diagnosis and treatment of neurological disorders, today announced initiation of a...
Email
Text